Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chrysalis Ventures is a venture capital firm based in Louisville, Kentucky, that focuses on early-stage and growth-stage investments in the healthcare and technology sectors. Founded in 1993, the firm manages over $400 million in committed capital and primarily targets companies located in the Midwest and Southern United States. Its healthcare investment strategy covers a broad spectrum, including healthcare services, healthcare information technology, and medical devices. The firm is led by experienced professionals, including Chairman David A. Jones, Jr., and is recognized for its deep roots in the healthcare industry. Chrysalis acts as a strategic partner to its portfolio companies, leveraging its extensive network to drive growth and operational excellence. For a biotech analyst, Chrysalis represents a key regional financier for healthcare infrastructure and service-oriented innovations rather than direct drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chrysalis Ventures.